The Valley Desk

NCT01535053 · Interventional trial

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

Overall registry status Completed

Phase 3

Conditions Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor, FIGO Stage III Gestational Trophoblastic Tumor, Hydatidiform Mole

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov